Auswahl der wissenschaftlichen Literatur zum Thema „Metalloproteinases Inhibitors Therapeutic use“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Metalloproteinases Inhibitors Therapeutic use" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Metalloproteinases Inhibitors Therapeutic use":
Ganea, E., M. Trifan, A. C. Laslo, G. Putina und C. Cristescu. „Matrix metalloproteinases: useful and deleterious“. Biochemical Society Transactions 35, Nr. 4 (20.07.2007): 689–91. http://dx.doi.org/10.1042/bst0350689.
Jakubowska, Katarzyna, Anna Pryczynicz, Piotr Iwanowicz, Andrzej Niewiński, Elżbieta Maciorkowska, Jerzy Hapanowicz, Dorota Jagodzińska, Andrzej Kemona und Katarzyna Guzińska-Ustymowicz. „Expressions of Matrix Metalloproteinases (MMP-2, MMP-7, and MMP-9) and Their Inhibitors (TIMP-1, TIMP-2) in Inflammatory Bowel Diseases“. Gastroenterology Research and Practice 2016 (2016): 1–7. http://dx.doi.org/10.1155/2016/2456179.
De, S., J. E. Fenton und A. S. Jones. „Matrix metalloproteinases and their inhibitors in non-neoplastic otorhinolaryngological disease“. Journal of Laryngology & Otology 119, Nr. 6 (Juni 2005): 436–42. http://dx.doi.org/10.1258/0022215054273269.
Titovska, S. O. „EFFECTIVENESS OF MATRIX METALLOPROTEINASES INHIBITORS FOR PREVENTIVE TREATMENT OF GENERALIZED PERIODONTITIS“. Ukrainian Dental Almanac, Nr. 2 (27.06.2022): 10–15. http://dx.doi.org/10.31718/2409-0255.2.2022.02.
Beletskaya, Inessa Stanislavovna, und Sergey Yurievich Astakhov. „The role of matrix metalloproteinases in glaucoma pathogenesis“. Ophthalmology journal 8, Nr. 3 (15.12.2015): 28–43. http://dx.doi.org/10.17816/ov2015328-43.
Docherty, Andy J., Tom Crabbe, James P. O'Connell und Colin R. Groom. „Proteases as drug targets“. Biochemical Society Symposia 70 (01.09.2003): 147–61. http://dx.doi.org/10.1042/bss0700147.
Elgezawi, Moataz, Rasha Haridy, Khalid Almas, Moamen A. Abdalla, Omar Omar, Hatem Abuohashish, Abeer Elembaby, Uta Christine Wölfle, Yasir Siddiqui und Dalia Kaisarly. „Matrix Metalloproteinases in Dental and Periodontal Tissues and Their Current Inhibitors: Developmental, Degradational and Pathological Aspects“. International Journal of Molecular Sciences 23, Nr. 16 (11.08.2022): 8929. http://dx.doi.org/10.3390/ijms23168929.
Doll, Carla U., Sabine Niebert und Janina Burk. „Mesenchymal Stromal Cells Adapt to Chronic Tendon Disease Environment with an Initial Reduction in Matrix Remodeling“. International Journal of Molecular Sciences 22, Nr. 23 (26.11.2021): 12798. http://dx.doi.org/10.3390/ijms222312798.
Cho, Chul-Hyun, Kwang-Soon Song, Beom-Soo Kim, Du Hwan Kim und Yun-Mee Lho. „Biological Aspect of Pathophysiology for Frozen Shoulder“. BioMed Research International 2018 (2018): 1–8. http://dx.doi.org/10.1155/2018/7274517.
Laghezza, Antonio, Luca Piemontese, Leonardo Brunetti, Alessia Caradonna, Mariangela Agamennone, Fulvio Loiodice und Paolo Tortorella. „(2-Aminobenzothiazole)-Methyl-1,1-Bisphosphonic Acids: Targeting Matrix Metalloproteinase 13 Inhibition to the Bone“. Pharmaceuticals 14, Nr. 2 (24.01.2021): 85. http://dx.doi.org/10.3390/ph14020085.
Dissertationen zum Thema "Metalloproteinases Inhibitors Therapeutic use":
Tang, Wing-yan, und 鄧詠欣. „Curcumin inhibits cancer cells migration and invasion of tongue carcinoma through down-regulation of matrix metalloproteinase-10“. Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2012. http://hub.hku.hk/bib/B47869768.
published_or_final_version
Surgery
Master
Master of Philosophy
Roach, Denise Margaret. „Upregulation of matrix metalloproteinases -2 and -9 and type IV collagen degradation in skeletal muscle reperfusion injury“. Title page, contents and abstract only, 2002. http://web4.library.adelaide.edu.au/theses/09MD/09mdr6281.pdf.
Peng, Xiaofang, und 彭晓芳. „Naturally occurring inhibitors against the formation of advanced glycation endproducts“. Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2010. http://hub.hku.hk/bib/B44892706.
Sun, Wentao, und 孙文韬. „The effects of Panax notoginseng extracts and its components on TNF-alpha induced MMP-9 expression and activity“. Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2014. http://hdl.handle.net/10722/207686.
published_or_final_version
Paediatrics and Adolescent Medicine
Master
Master of Philosophy
Chan, Hoi-ching, und 陳凱靜. „Heat shock protein 90 inhibitor 17-AAG potentiates anticancer activityof bortezomib in NK cell malignancies“. Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2011. http://hub.hku.hk/bib/B46632025.
He, Ru, und 何茹. „Effectiveness and toxicity of aromatase inhabitors [i.e. inhibitors] in adjuvant therapy for hormone receptor positive postmenopausalbreast cancer: a meta-analysis“. Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2011. http://hub.hku.hk/bib/B46936026.
Gu, Baoying. „Selective increase of neuronal cyclooxygenase-2 (COX-2) expression in vulnerable brain regions of rats with experimental Wernicke's encephalopathy : effects of nimesulide“. Thesis, McGill University, 2007. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=112627.
Ho, Kwun-wai, und 何冠威. „Angiotensin converting enzyme inhibitor alone or in combination with angiotensin II type I receptor blocker in patients with chronicproteinuric nephropathies: a systemic reviewof clinical trials“. Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2005. http://hub.hku.hk/bib/B45010687.
Scrivens, Paul James. „Regulation and chemotherapeutic targeting of human Cdc25A phosphatase“. Thesis, McGill University, 2007. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=103293.
Wong, Carmen, und 黃嘉敏. „A systematic review of the drug sorafenib in extending survival time in patients with hepatocellular carcinoma“. Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2011. http://hub.hku.hk/bib/B46942865.
Bücher zum Thema "Metalloproteinases Inhibitors Therapeutic use":
Rotheim, Philip. New developments in therapeutic enzyme inhibitors and receptor blockers. Norwalk, CT: Business Communications Co., 1996.
Goudot-Perrot, Andrée. Metabolic inhibitors: Antibiotics - antimitotics - psychotropics. Stuttgart: Schwer Verlag, 1992.
Co, Business Communications. New developments in therapeutic enzyme inhibitors and blockers. Norealk, CT: Business Communications Co., 2002.
George, Weinbaum, Giles Ralph E, Krell Robert D, New York Academy of Sciences. und American Thoracic Society, Hrsg. Pulmonary emphysema: The rationale for therapeutic intervention. New York, N.Y: New York Academy of Sciences, 1991.
PhD, Henderson Brian, und Bodmer Mark W, Hrsg. Therapeutic modulation of cytokines. Boca Raton, Fla: CRC Press, 1996.
K, Ghosh Arun. Aspartic acid proteases as therapeutic targets. Weinheim: Wiley-VCH, 2010.
K, Ghosh Arun. Aspartic acid proteases as therapeutic targets. Weinheim: Wiley-VCH, 2010.
Philippe, Taupin, Hrsg. The cystatin superfamily of proteinase inhibitors. New York: Nova Science Publishers, 2007.
Osiadacz, Jarosław. Inhibitory topoizomeraz DNA i ich zastosowanie w chemioterapii. Wrocław: Oficyna Wydawnicza Politechniki Wrocławskiej, 1999.
Li, William W. The antiangiogenic therapy self help book for cancer patients. Cambridge, Mass: Angiogenesis Foundation, 2003.
Buchteile zum Thema "Metalloproteinases Inhibitors Therapeutic use":
Darby, Ian A., und Alexis Desmoulière. „Scar Formation: Cellular Mechanisms“. In Textbook on Scar Management, 19–26. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-44766-3_3.
Thiemermann, Christoph. „Combined Use of Nitric Oxide and Nitric Oxide Synthase Inhibitors as a Possible Therapeutic Approach“. In Nitric Oxide in Pulmonary Processes: Role in Physiology and Pathophysiology of Lung Disease, 209–25. Basel: Birkhäuser Basel, 2000. http://dx.doi.org/10.1007/978-3-0348-8474-7_12.
Jung, Jin G., und Anne Le. „Metabolism of Immune Cells in the Tumor Microenvironment“. In The Heterogeneity of Cancer Metabolism, 173–85. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-65768-0_13.
„Inhibitors of Matrix Metalloproteinases: Design, Structure and Therapeutic Applications“. In Frontiers in Medicinal Chemistry - (Volume 1), herausgegeben von Jerry W. Skiles, Nina C. Gonnella und Arco Y. Jeng, 29–75. BENTHAM SCIENCE PUBLISHERS, 2012. http://dx.doi.org/10.2174/978160805204210401010029.
COURTNEY, M., S. JALLAT, D. CARVALLO, R. G. CRYSTAL, M. SCHAPIRA und C. ROITSCH. „ANTIPROTEASE ENGINEERING: NEW PROTEASE INHIBITORS FOR THERAPEUTIC USE“. In Protides of the Biological Fluids, 493–95. Elsevier, 1987. http://dx.doi.org/10.1016/b978-0-08-035588-7.50113-8.
Nevzorova, Vera, Tatiana Brodskaya und Eugeny Gilifanov. „Smoking and COPD: Endothelium-Related and Neuro-mediated Emphysema Mechanisms“. In Update in Respiratory Diseases. IntechOpen, 2020. http://dx.doi.org/10.5772/intechopen.85927.
Angeli, Andrea, und Claudiu T. Supuran. „Therapeutic Use of Carbonic Anhydrase Inhibitors and Their Multiple Drug Interactions“. In Pharmaceutical Biocatalysis, 73–98. Jenny Stanford Publishing, 2019. http://dx.doi.org/10.1201/9780429295034-3.
Ma, Zetong, Wenyan Fu, Changhai Lei und Shi Hu. „Use of MET kinase inhibitors to overcome cetuximab resistance in colorectal cancer“. In Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies, 113–17. Elsevier, 2023. http://dx.doi.org/10.1016/b978-0-12-821584-5.00019-5.
Keeling, David. „Therapeutic anticoagulation“. In Oxford Textbook of Medicine, herausgegeben von Jeremy Dwight, 3729–34. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198746690.003.0376.
Alayande, Kazeem A., Abdulwakeel A. Ajao und Mariam O. Oyedeji- Amusa. „Bioactive Compounds as Therapeutic Intervention in Bacterial Infections“. In Therapeutic Use of Plant Secondary Metabolites, 139–60. BENTHAM SCIENCE PUBLISHERS, 2022. http://dx.doi.org/10.2174/9789815050622122010009.
Konferenzberichte zum Thema "Metalloproteinases Inhibitors Therapeutic use":
Meng, Wilson S., Jeffrey R. Kovacs und Ellen S. Gawalt. „The Use of Non-Viral Nucleic Acids Carriers for the Modulation of Leukocytes“. In ASME 2008 Conference on Smart Materials, Adaptive Structures and Intelligent Systems. ASMEDC, 2008. http://dx.doi.org/10.1115/smasis2008-348.
Yalcin, Huseyin, Hissa Al-Thani und Samar Shurbaji. „Development and In Vivo Testing of Smart Nanoparticles for Enhanced Anti-Cancer Activity and Reduced Cardiotoxicity Associated with Tyrosine Kinase Inhibitors“. In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2021. http://dx.doi.org/10.29117/quarfe.2021.0088.
Arora, Rahul D. „Definition, etiopathogenesis, management and role of flouroquinolone prophylaxis in prevention of spontaneous bacterial peritonitis complicating malignant ascites“. In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685345.